Global Lou Gehrigs Disease Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 105

Report ID: 11056

Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), or Lou Gehrig's disease, is a specific disease which causes the death of neurons controlling voluntary muscles. Some also use the term motor neuron disease for a group of conditions of which ALS is the most common.

The global Lou Gehrigs Disease market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Lou Gehrigs Disease volume and value at global level, regional level and company level. From a global perspective, this report represents overall Lou Gehrigs Disease market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
AB Science
Avicena Group
Biogen
BrainStorm Therapeutics
Covis Pharmaceutical Inc.
Cytokinetics Inc.
Eisai Co. Ltd.
GlaxoSmithKline plc.
Ionis Pharmaceuticals, Inc.
Mitsubishi Tanabe Pharma Corp.
Neuralstem Inc.
Neuraltus Pharmaceuticals Inc.
Newron Pharmaceuticals S.p.A.
Nutra Pharma Corp.
Pharnext SAS
Q-Therapeutics Inc.

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Riluzole
Edaravone (Radicava)

Segment by Application
Hospital Pharmacies
Retail & Online Pharmacie

Table of Contents

Executive Summary
1 Lou Gehrigs Disease Market Overview
1.1 Product Overview and Scope of Lou Gehrigs Disease
1.2 Lou Gehrigs Disease Segment by Type
1.2.1 Global Lou Gehrigs Disease Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Riluzole
1.2.3 Edaravone (Radicava)
1.3 Lou Gehrigs Disease Segment by Application
1.3.1 Lou Gehrigs Disease Consumption Comparison by Application (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail & Online Pharmacie
1.4 Global Lou Gehrigs Disease Market by Region
1.4.1 Global Lou Gehrigs Disease Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Lou Gehrigs Disease Market Size
1.5.1 Global Lou Gehrigs Disease Revenue (2014-2025)
1.5.2 Global Lou Gehrigs Disease Production (2014-2025)

2 Global Lou Gehrigs Disease Market Competition by Manufacturers
2.1 Global Lou Gehrigs Disease Production Market Share by Manufacturers (2014-2019)
2.2 Global Lou Gehrigs Disease Revenue Share by Manufacturers (2014-2019)
2.3 Global Lou Gehrigs Disease Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Lou Gehrigs Disease Production Sites, Area Served, Product Types
2.5 Lou Gehrigs Disease Market Competitive Situation and Trends
2.5.1 Lou Gehrigs Disease Market Concentration Rate
2.5.2 Lou Gehrigs Disease Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Lou Gehrigs Disease Production Market Share by Regions
3.1 Global Lou Gehrigs Disease Production Market Share by Regions
3.2 Global Lou Gehrigs Disease Revenue Market Share by Regions (2014-2019)
3.3 Global Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Lou Gehrigs Disease Production
3.4.1 North America Lou Gehrigs Disease Production Growth Rate (2014-2019)
3.4.2 North America Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Lou Gehrigs Disease Production
3.5.1 Europe Lou Gehrigs Disease Production Growth Rate (2014-2019)
3.5.2 Europe Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Lou Gehrigs Disease Production (2014-2019)
3.6.1 China Lou Gehrigs Disease Production Growth Rate (2014-2019)
3.6.2 China Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Lou Gehrigs Disease Production (2014-2019)
3.7.1 Japan Lou Gehrigs Disease Production Growth Rate (2014-2019)
3.7.2 Japan Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Lou Gehrigs Disease Consumption by Regions
4.1 Global Lou Gehrigs Disease Consumption by Regions
4.2 North America Lou Gehrigs Disease Consumption (2014-2019)
4.3 Europe Lou Gehrigs Disease Consumption (2014-2019)
4.4 China Lou Gehrigs Disease Consumption (2014-2019)
4.5 Japan Lou Gehrigs Disease Consumption (2014-2019)

5 Global Lou Gehrigs Disease Production, Revenue, Price Trend by Type
5.1 Global Lou Gehrigs Disease Production Market Share by Type (2014-2019)
5.2 Global Lou Gehrigs Disease Revenue Market Share by Type (2014-2019)
5.3 Global Lou Gehrigs Disease Price by Type (2014-2019)
5.4 Global Lou Gehrigs Disease Production Growth by Type (2014-2019)

6 Global Lou Gehrigs Disease Market Analysis by Applications
6.1 Global Lou Gehrigs Disease Consumption Market Share by Application (2014-2019)
6.2 Global Lou Gehrigs Disease Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Lou Gehrigs Disease Business
7.1 AB Science
7.1.1 AB Science Lou Gehrigs Disease Production Sites and Area Served
7.1.2 Lou Gehrigs Disease Product Introduction, Application and Specification
7.1.3 AB Science Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Avicena Group
7.2.1 Avicena Group Lou Gehrigs Disease Production Sites and Area Served
7.2.2 Lou Gehrigs Disease Product Introduction, Application and Specification
7.2.3 Avicena Group Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Biogen
7.3.1 Biogen Lou Gehrigs Disease Production Sites and Area Served
7.3.2 Lou Gehrigs Disease Product Introduction, Application and Specification
7.3.3 Biogen Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 BrainStorm Therapeutics
7.4.1 BrainStorm Therapeutics Lou Gehrigs Disease Production Sites and Area Served
7.4.2 Lou Gehrigs Disease Product Introduction, Application and Specification
7.4.3 BrainStorm Therapeutics Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Covis Pharmaceutical Inc.
7.5.1 Covis Pharmaceutical Inc. Lou Gehrigs Disease Production Sites and Area Served
7.5.2 Lou Gehrigs Disease Product Introduction, Application and Specification
7.5.3 Covis Pharmaceutical Inc. Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Cytokinetics Inc.
7.6.1 Cytokinetics Inc. Lou Gehrigs Disease Production Sites and Area Served
7.6.2 Lou Gehrigs Disease Product Introduction, Application and Specification
7.6.3 Cytokinetics Inc. Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Eisai Co. Ltd.
7.7.1 Eisai Co. Ltd. Lou Gehrigs Disease Production Sites and Area Served
7.7.2 Lou Gehrigs Disease Product Introduction, Application and Specification
7.7.3 Eisai Co. Ltd. Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 GlaxoSmithKline plc.
7.8.1 GlaxoSmithKline plc. Lou Gehrigs Disease Production Sites and Area Served
7.8.2 Lou Gehrigs Disease Product Introduction, Application and Specification
7.8.3 GlaxoSmithKline plc. Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Ionis Pharmaceuticals, Inc.
7.9.1 Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Production Sites and Area Served
7.9.2 Lou Gehrigs Disease Product Introduction, Application and Specification
7.9.3 Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Mitsubishi Tanabe Pharma Corp.
7.10.1 Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Production Sites and Area Served
7.10.2 Lou Gehrigs Disease Product Introduction, Application and Specification
7.10.3 Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 Neuralstem Inc.
7.12 Neuraltus Pharmaceuticals Inc.
7.13 Newron Pharmaceuticals S.p.A.
7.14 Nutra Pharma Corp.
7.15 Pharnext SAS
7.16 Q-Therapeutics Inc.

8 Lou Gehrigs Disease Manufacturing Cost Analysis
8.1 Lou Gehrigs Disease Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Lou Gehrigs Disease
8.4 Lou Gehrigs Disease Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Lou Gehrigs Disease Distributors List
9.3 Lou Gehrigs Disease Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Lou Gehrigs Disease Market Forecast
11.1 Global Lou Gehrigs Disease Production, Revenue Forecast
11.1.1 Global Lou Gehrigs Disease Production Growth Rate Forecast (2019-2025)
11.1.2 Global Lou Gehrigs Disease Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Lou Gehrigs Disease Price and Trend Forecast (2019-2025)
11.2 Global Lou Gehrigs Disease Production Forecast by Regions (2019-2025)
11.2.1 North America Lou Gehrigs Disease Production, Revenue Forecast (2019-2025)
11.2.2 Europe Lou Gehrigs Disease Production, Revenue Forecast (2019-2025)
11.2.3 China Lou Gehrigs Disease Production, Revenue Forecast (2019-2025)
11.2.4 Japan Lou Gehrigs Disease Production, Revenue Forecast (2019-2025)
11.3 Global Lou Gehrigs Disease Consumption Forecast by Regions (2019-2025)
11.3.1 North America Lou Gehrigs Disease Consumption Forecast (2019-2025)
11.3.2 Europe Lou Gehrigs Disease Consumption Forecast (2019-2025)
11.3.3 China Lou Gehrigs Disease Consumption Forecast (2019-2025)
11.3.4 Japan Lou Gehrigs Disease Consumption Forecast (2019-2025)
11.4 Global Lou Gehrigs Disease Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Lou Gehrigs Disease Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer